Neurocrine Biosciences Inc (NBIX) stock outlook 2012

Neurocrine Biosciences Inc (NBIX) stock outlook 2012 : Neurocrine Biosciences Inc (NBIX): The current trading price of this stock in the market is approximately $9 per share. There is a high probability that this might remain unchanged for some time. At its current price, the company's market capitalization is close to $571 million and the 52-week trading range is between $5 and $10 per share as an approximate figure. Earnings per share are nearly $1 and the price-to-earnings (P/E) ratio is 13.

This stock is a much safer investment and has a beta of 0.32. Income growth is showing positive trends and the profit margins are growing too. Neurocrine Biosciences has been given a rating of 7 out of 10 by industry experts because of low risk and high growth potential. It has been categorized as one of the healthcare stocks which are in the spotlight for investors.

There had been some problems being faced in the earlier quarters of the previous year. However, by the last quarter, the situation had improved and the stock has been able to stabilize itself. In my opinion, this is a safer option to invest in right now.

Forecast Earnings Growth

This year, analysts are forecasting earnings growth of 0 over last year.Analysts expect earnings growth next year of -0.16 over this year's forecasted earnings.

For the latest updates on the stock market, visit Stock Market Today For the latest updates PRESS CTR + D or visit Stock Market news Today

Related Post: